COVID-19 Vaccine (ChAdOx1-S [Recombinant])

COVID-19 Vaccine (ChAdOx1-S [Recombinant])

【Active constituent】	Using a replication-deficient chimpanzee adenovirus (ChAdOx1) as the vector. The adenovirus-vectored recombinant COVID-19 vaccine is inoculated into HEK293 cells, followed by culturing, feeding, viral purification, formulation, and packaging to produce the final vaccine product.
【Strengths】	10 multidose vials (10 doses per vial-0.5 ml per dose)
【Storage Conditions】	Store and transport at 2-8°C away from light

Advantages of Adenoviral Vectors:

Broad host range and does not integrate into human genes.
Multiple serotypes available for selection.
Adenoviral vectors carrying protective antigen genes can stimulate strong humoral and cellular immune responses.
Adenoviral vector vaccines can induce mucosal immunity via the gastrointestinal or respiratory tract, such as oral or nasal administration.
Adenoviral vector vaccines can be formulated into various dosage forms, such as lyophilized powder or oral formulations, to extend shelf life.
No need for adjuvants.